• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用集成过程模型的实验整体设计

Holistic Design of Experiments Using an Integrated Process Model.

作者信息

Oberleitner Thomas, Zahel Thomas, Pretzner Barbara, Herwig Christoph

机构信息

Competence Center CHASE GmbH, Ghegastraße 3, Top 3.2, 1030 Vienna, Austria.

Körber Pharma Austria GmbH, PAS-X Savvy, Mariahilferstraße 88A/1/9, 1070 Vienna, Austria.

出版信息

Bioengineering (Basel). 2022 Nov 3;9(11):0. doi: 10.3390/bioengineering9110643.

DOI:10.3390/bioengineering9110643
PMID:36354553
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9687958/
Abstract

Statistical experimental designs such as factorial, optimal, or definitive screening designs represent the state of the art in biopharmaceutical process characterization. However, such methods alone do not leverage the fact that processes operate as a mutual interplay of multiple steps. Instead, they aim to investigate only one process step at a time. Here, we want to develop a new experimental design method that seeks to gain information about final product quality, placing the right type of run at the right unit operation. This is done by minimizing the simulated out-of-specification rate of an integrated process model comprised of a chain of regression models that map process parameters to critical quality attributes for each unit operation. Unit operation models are connected by passing their response to the next unit operation model as a load parameter, as is done in real-world manufacturing processes. The proposed holistic DoE (hDoE) method is benchmarked against standard process characterization approaches in a set of in silico simulation studies where data are generated by different ground truth processes to illustrate the validity over a range of scenarios. Results show that the hDoE approach leads to a >50% decrease in experiments, even for simple cases, and, at the same time, achieves the main goal of process development, validation, and manufacturing to consistently deliver product quality.

摘要

统计实验设计,如析因设计、优化设计或确定性筛选设计,代表了生物制药工艺表征的最新技术水平。然而,仅靠这些方法并不能利用工艺作为多个步骤相互作用的这一事实。相反,它们旨在一次只研究一个工艺步骤。在此,我们希望开发一种新的实验设计方法,该方法旨在获取有关最终产品质量的信息,在正确的单元操作中进行正确类型的运行。这是通过最小化由一系列回归模型组成的集成过程模型的模拟不合格率来实现的,这些回归模型将每个单元操作的过程参数映射到关键质量属性。单元操作模型通过将其响应作为负载参数传递给下一个单元操作模型来连接,就像在实际制造过程中那样。在一组计算机模拟研究中,将所提出的整体实验设计(hDoE)方法与标准工艺表征方法进行了基准测试,在这些模拟研究中,数据由不同的真实过程生成,以说明该方法在一系列场景中的有效性。结果表明,即使对于简单的情况,hDoE方法也能使实验次数减少50%以上,同时实现工艺开发、验证和制造的主要目标,即始终如一地提供产品质量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2945/9687958/ec4cd0df363a/bioengineering-09-00643-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2945/9687958/062e11bb8b11/bioengineering-09-00643-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2945/9687958/946af3e21d98/bioengineering-09-00643-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2945/9687958/cc62e911ab8c/bioengineering-09-00643-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2945/9687958/99b1f59b3d91/bioengineering-09-00643-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2945/9687958/d1561dcdd629/bioengineering-09-00643-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2945/9687958/ec7967bc86a6/bioengineering-09-00643-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2945/9687958/ae5b07f9a086/bioengineering-09-00643-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2945/9687958/d7cbff7ed35a/bioengineering-09-00643-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2945/9687958/1fe050bae3fe/bioengineering-09-00643-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2945/9687958/ec4cd0df363a/bioengineering-09-00643-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2945/9687958/062e11bb8b11/bioengineering-09-00643-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2945/9687958/946af3e21d98/bioengineering-09-00643-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2945/9687958/cc62e911ab8c/bioengineering-09-00643-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2945/9687958/99b1f59b3d91/bioengineering-09-00643-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2945/9687958/d1561dcdd629/bioengineering-09-00643-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2945/9687958/ec7967bc86a6/bioengineering-09-00643-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2945/9687958/ae5b07f9a086/bioengineering-09-00643-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2945/9687958/d7cbff7ed35a/bioengineering-09-00643-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2945/9687958/1fe050bae3fe/bioengineering-09-00643-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2945/9687958/ec4cd0df363a/bioengineering-09-00643-g010.jpg

相似文献

1
Holistic Design of Experiments Using an Integrated Process Model.使用集成过程模型的实验整体设计
Bioengineering (Basel). 2022 Nov 3;9(11):0. doi: 10.3390/bioengineering9110643.
2
Integrated Process Modeling-A Process Validation Life Cycle Companion.集成过程建模——过程验证生命周期的辅助工具
Bioengineering (Basel). 2017 Oct 17;4(4):86. doi: 10.3390/bioengineering4040086.
3
Integrated process model for the prediction of biopharmaceutical manufacturing chromatography and adjustment steps.用于预测生物制药制造色谱和调整步骤的综合工艺模型。
J Chromatogr A. 2022 Oct 11;1681:463421. doi: 10.1016/j.chroma.2022.463421. Epub 2022 Aug 13.
4
Application of quality by design principles to the development and technology transfer of a major process improvement for the manufacture of a recombinant protein.应用质量源于设计理念于重组蛋白生产中重大工艺改进的开发和技术转移。
Biotechnol Prog. 2011 Nov-Dec;27(6):1718-29. doi: 10.1002/btpr.672. Epub 2011 Sep 21.
5
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
6
Accurate definition of control strategies using cross validated stepwise regression and Monte Carlo simulation.使用交叉验证逐步回归和蒙特卡罗模拟对控制策略进行准确界定。
J Biotechnol. 2019;306S:100006. doi: 10.1016/j.btecx.2019.100006. Epub 2019 Apr 28.
7
Specification-driven acceptance criteria for validation of biopharmaceutical processes.生物制药工艺验证的规范驱动验收标准
Front Bioeng Biotechnol. 2022 Sep 23;10:1010583. doi: 10.3389/fbioe.2022.1010583. eCollection 2022.
8
Characterization of a Saccharomyces cerevisiae fermentation process for production of a therapeutic recombinant protein using a multivariate Bayesian approach.使用多元贝叶斯方法对酿酒酵母发酵生产治疗性重组蛋白过程的表征。
Biotechnol Prog. 2016 May;32(3):799-812. doi: 10.1002/btpr.2264. Epub 2016 Apr 20.
9
Developing an efficient scheduling template of a chemotherapy treatment unit: A case study.制定化疗治疗单元的高效排班模板:一项案例研究。
Australas Med J. 2011;4(10):575-88. doi: 10.4066/AMJ.2011.837. Epub 2011 Oct 31.
10
Architectural and Technological Improvements to Integrated Bioprocess Models towards Real-Time Applications.面向实时应用的集成生物过程模型的架构与技术改进
Bioengineering (Basel). 2022 Oct 9;9(10):534. doi: 10.3390/bioengineering9100534.

本文引用的文献

1
Architectural and Technological Improvements to Integrated Bioprocess Models towards Real-Time Applications.面向实时应用的集成生物过程模型的架构与技术改进
Bioengineering (Basel). 2022 Oct 9;9(10):534. doi: 10.3390/bioengineering9100534.
2
Specification-driven acceptance criteria for validation of biopharmaceutical processes.生物制药工艺验证的规范驱动验收标准
Front Bioeng Biotechnol. 2022 Sep 23;10:1010583. doi: 10.3389/fbioe.2022.1010583. eCollection 2022.
3
Confidence, prediction, and tolerance in linear mixed models.
线性混合模型中的置信度、预测和容忍度。
Stat Med. 2019 Dec 30;38(30):5603-5622. doi: 10.1002/sim.8386. Epub 2019 Oct 28.
4
Demonstration of robust host cell protein clearance in biopharmaceutical downstream processes.生物制药下游工艺中强大的宿主细胞蛋白清除能力的证明。
Biotechnol Prog. 2008 May-Jun;24(3):615-22. doi: 10.1021/bp070396j. Epub 2008 Apr 15.
5
Using statistical analysis for setting process validation acceptance criteria for biotech products.运用统计分析来设定生物科技产品的工艺验证验收标准。
Biotechnol Prog. 2007 Jan-Feb;23(1):55-60. doi: 10.1021/bp060359c.
6
Statistical tools for setting in-process acceptance criteria.用于设定过程中验收标准的统计工具。
Dev Biol (Basel). 2003;113:17-25.
7
Considerations in performing virus spiking experiments and process validation studies.进行病毒加标实验和工艺验证研究时的注意事项。
Dev Biol Stand. 1993;81:221-9.